Skip to content
Screener

PTC Therapeutics PTCT Business Segments — Intangible Amortization

Similar metrics at other companies

Kemper logo
KMPRLife Insurance — Intangible Amortization
$1.8M+5.9%
lululemon athletica logo
LULUAmericas — Intangible Amortization
$0
Helios Technologies logo
HLIOElectronics — Intangible Amortization
$0
Helios Technologies logo
HLIOHydraulics — Intangible Amortization
$0
AeroVironment logo
AVAVUxs — Intangible Amortization
$4.26M
Restoration Hardware logo
RHRH — Intangible Amortization
-$30K-42.9%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$5.78B+41.9%
Enterprise value$5.34B+54.9%
P/E7.1×
P/S+4.7×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:32 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001070081-26-000012
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Interest income$$(17,985)(17,245)
Interest expense67,01551,337
Income tax expense34763,266
Depreciation3,8063,458
Amortization11,5813,798
All other (b)43,12540,809
Total other segment items$$107,889145,423

Item 1. Financial Statements (unaudited)

FAQ

What is PTC Therapeutics's business segments — intangible amortization?
PTC Therapeutics (PTCT) reported business segments — intangible amortization of $11.58M in Q1 2026.
How has PTC Therapeutics's business segments — intangible amortization changed year-over-year?
PTC Therapeutics's business segments — intangible amortization increased by 204.9% year-over-year, from $3.8M to $11.58M.
What is the long-term trend for PTC Therapeutics's business segments — intangible amortization?
Over 2 years (2023 to 2025), PTC Therapeutics's business segments — intangible amortization has grown at a -66.7% compound annual growth rate (CAGR), from $222.64M to $24.74M.
What does business segments — intangible amortization mean?
This metric represents the periodic expense recognized for the consumption of intangible assets, such as patents, licenses, or acquired intellectual property, within the Life Science segment. It reflects the gradual write-down of the value of non-physical assets that contribute to the segment's competitive advantage. Investors use this to evaluate the impact of past acquisitions and R&D investments on current earnings.

Ask your AI about PTC Therapeutics's business segments — intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude